FDA Import Refusal AEK-3505403-8/21/1 — FARMAVANZA
The FDA refused shipment AEK-3505403-8/21/1 from FARMAVANZA (Guatemala) on Jul 13, 2023. The refused product falls under Drugs and Biologics — DICLOFENAC SODIUM (ANTI-INFLAMMATORY). Cited charges: 118,3280,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jul 13, 2023
- Country
- Guatemala
- Product Category
- Drugs and Biologics
- Product Code
- 62GCA18 DICLOFENAC SODIUM (ANTI-INFLAMMATORY)
- Charges
- 118,3280,75